Despite the performance, the company expects to be at the lower end of its revenue guidance window for the year of between €2 ...

With flu season underway and new, developing COVID-19 strains ... Here's what they found. Pfizer-BioNTech: The Pfizer-BioNTech vaccine was the first COVID vaccine to receive FDA Emergency Use ...

Despite the potential in oncology, BNTX's current valuation is high relative to its non-COVID revenue prospects, warranting a ...

German drugmaker BioNTech on Monday lowered its guidance for full-year revenue, citing COVID-19 uptake and price levels, inventory write-downs and Pfizer charges.

The Centers for Disease Control and Prevention (CDC) recommends the Moderna and Pfizer-BioNTech COVID-19 vaccines for kids as ...

In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three ...

a new presentation of the vaccine that allows for refrigerated storage conditions. On September 24, 2024, the EC approved BioNTech and Pfizer’s Omicron KP.2-adapted COVID-19 vaccine. The companies ...

The new vaccines are nearly identical to their predecessors, except that they now target JN.1-lineage variants of omicron ...